beta

APM

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Market Cap:

Primary Exchange:

Website: /stocks/apm

Shares Outstanding:

Float:

Dividend: (%)

Beta:

Sector:

Industry:

Short Interest ():

Ethical Flags

Longest drawdown: 87 trading days

From: 2018-12-24 To: 2019-05-01

Lowest Point:

Aptorum Group to Be Newly Added to MSCI HK Micro Cap Index

via: Business Wire at 2019-05-22 04:00:00:000

Aptorum Group Limited (Nasdaq: APM) (the Company) a pharmaceutical company dedicated to developing and commercializing a broad range of therapeutic and diagnostic technologies to tackle unmet medical needs, announced today the Companys addition to the Morgan Stanley C… read more...

Aptorum Group to Be Newly Added to MSCI HK Micro Cap Index

via: Business Wire at 2019-05-22 04:00:00:000

Aptorum Group Limited (Nasdaq: APM) (the Company) a pharmaceutical company dedicated to developing and commercializing a broad range of therapeutic and diagnostic technologies to tackle unmet medical needs, announced today the Companys addition to the Morgan Stanley C… read more...

Aeneas Capital and Pyrinas Target Launch of US$120m Fund to Develop Co-Working Laboratory Ecosystems for Life Sciences Start-Ups in the United States

via: Business Wire at 2019-05-15 17:00:00:000

Aeneas Capital and Pyrinas, both affiliated companies to Aptorum Group Ltd (Nasdaq: APM), is launching its flagship fund - Pyrinas US Healthcare Real Estate Fund 1 SP to acquire and develop co-working space and incubator facilities for the life sciences sector in the United States… read more...

Aeneas Capital and Pyrinas Target Launch of US$120m Fund to Develop Co-Working Laboratory Ecosystems for Life Sciences Start-Ups in the United States

via: Business Wire at 2019-05-15 17:00:00:000

Aeneas Capital and Pyrinas, both affiliated companies to Aptorum Group Ltd (Nasdaq: APM), is launching its flagship fund - Pyrinas US Healthcare Real Estate Fund 1 SP to acquire and develop co-working space and incubator facilities for the life sciences sector in the United States… read more...

Aeneas Capital and Pyrinas Target Launch of US$120m Fund to Develop Co-Working Laboratory Ecosystems for Life Sciences Start-Ups in the United States

via: Business Wire at 2019-05-15 17:00:00:000

Aeneas Capital and Pyrinas, both affiliated companies to Aptorum Group Ltd (Nasdaq: APM), is launching its flagship fund - Pyrinas US Healthcare Real Estate Fund 1 SP to acquire and develop co-working space and incubator facilities for the life sciences sector in the United States… read more...

Aptorum Group's Subsidiary - Claves Life Sciences Limited Establishes Novel Therapeutic Platform for Treatment of Various Diseases via Modulation of the Chemical Signaling Relating to Gut Microbiota

via: Business Wire at 2019-05-06 04:00:00:000

Claves Life Sciences Limited, a wholly owned subsidiary of Aptorum Group Limited ("Aptorum") (Nasdaq: APM), is excited to announce the establishment of a novel therapeutic platform for the treatment of various diseases via modulation of the chemical signaling relating to gut microbiota. The … read more...

Aptorum Group's Subsidiary - Claves Life Sciences Limited Establishes Novel Therapeutic Platform for Treatment of Various Diseases via Modulation of the Chemical Signaling Relating to Gut Microbiota

via: Business Wire at 2019-05-06 04:00:00:000

Claves Life Sciences Limited, a wholly owned subsidiary of Aptorum Group Limited ("Aptorum") (Nasdaq: APM), is excited to announce the establishment of a novel therapeutic platform for the treatment of various diseases via modulation of the chemical signaling relating to gut microbiota. The … read more...

Aptorum Group's Subsidiary - Claves Life Sciences Limited Establishes Novel Therapeutic Platform for Treatment of Various Diseases via Modulation of the Chemical Signaling Relating to Gut Microbiota

via: Business Wire at 2019-05-06 04:00:00:000

Claves Life Sciences Limited, a wholly owned subsidiary of Aptorum Group Limited ("Aptorum") (Nasdaq: APM), is excited to announce the establishment of a novel therapeutic platform for the treatment of various diseases via modulation of the chemical signaling relating to gut microbiota. The … read more...

USD$90 Million Initiative between A*Star, Aptorum Group and Aeneas Capital to Drive Healthcare Innovations

via: Business Wire at 2019-04-24 04:00:00:000

Aptorum Group Limited (Nasdaq: APM), Aeneas Capital Limited, and A*ccelerate Technologies Pte Ltd, the enterprise office of the Agency for Science, Technology and Research (A*STAR), have signed a USD$90 million agreement to co-create local deep tech start-ups in the healthcare and life scien… read more...

USD$90 Million Initiative between A*Star, Aptorum Group and Aeneas Capital to Drive Healthcare Innovations

via: Business Wire at 2019-04-24 04:00:00:000

Aptorum Group Limited (Nasdaq: APM), Aeneas Capital Limited, and A*ccelerate Technologies Pte Ltd, the enterprise office of the Agency for Science, Technology and Research (A*STAR), have signed a USD$90 million agreement to co-create local deep tech start-ups in the healthcare and life scien… read more...

USD$90 Million Initiative between A*Star, Aptorum Group and Aeneas Capital to Drive Healthcare Innovations

via: Business Wire at 2019-04-24 04:00:00:000

Aptorum Group Limited (Nasdaq: APM), Aeneas Capital Limited, and A*ccelerate Technologies Pte Ltd, the enterprise office of the Agency for Science, Technology and Research (A*STAR), have signed a USD$90 million agreement to co-create local deep tech start-ups in the healthcare and life scien… read more...

Aptorum Group's Smart Pharma announces launch of its asset backed Smart Pharma token (SMPT), supported by its computational repurposed drug discovery platform Smart-ACT(TM)

via: Business Wire at 2019-04-24 00:30:00:000

Aptorum Group Limited (Nasdaq:APM) is excited to announce the launch and issuance of its asset backed Smart Pharma Token ( SMPT ) by its wholly owned subsidiary group, Smart Pharma group and Smart Pharmaceutical Limited Partnership ( SPLP ) targeted in May 201… read more...

Aptorum Group Establishes Smart Pharma to Focus on Computational Repurposed Drug Discovery for Orphan and Unmet Diseases

via: Business Wire at 2019-04-24 00:30:00:000

Aptorum Group Limited (Nasdaq: APM) today announced the establishment of a new subsidiary group, Smart Pharma (SmartP), which operates its novel computational repurposed drug discovery, modeling and validation platform, together referred to as the Smart-ACT TM &#x201D… read more...

Aptorum Group Establishes Smart Pharma to Focus on Computational Repurposed Drug Discovery for Orphan and Unmet Diseases

via: Business Wire at 2019-04-24 00:30:00:000

Aptorum Group Limited (Nasdaq: APM) today announced the establishment of a new subsidiary group, Smart Pharma (SmartP), which operates its novel computational repurposed drug discovery, modeling and validation platform, together referred to as the Smart-ACT TM &#x201D… read more...

Aptorum Group's Smart Pharma announces launch of its asset backed Smart Pharma token (SMPT), supported by its computational repurposed drug discovery platform Smart-ACT(TM)

via: Business Wire at 2019-04-24 00:30:00:000

Aptorum Group Limited (Nasdaq:APM) is excited to announce the launch and issuance of its asset backed Smart Pharma Token ( SMPT ) by its wholly owned subsidiary group, Smart Pharma group and Smart Pharmaceutical Limited Partnership ( SPLP ) targeted in May 201… read more...

Aptorum Group Establishes Smart Pharma to Focus on Computational Repurposed Drug Discovery for Orphan and Unmet Diseases

via: Business Wire at 2019-04-24 00:30:00:000

Aptorum Group Limited (Nasdaq: APM) today announced the establishment of a new subsidiary group, Smart Pharma (SmartP), which operates its novel computational repurposed drug discovery, modeling and validation platform, together referred to as the Smart-ACT TM &#x201D… read more...

Aptorum Group's Smart Pharma announces launch of its asset backed Smart Pharma token (SMPT), supported by its computational repurposed drug discovery platform Smart-ACT(TM)

via: Business Wire at 2019-04-24 00:30:00:000

Aptorum Group Limited (Nasdaq:APM) is excited to announce the launch and issuance of its asset backed Smart Pharma Token ( SMPT ) by its wholly owned subsidiary group, Smart Pharma group and Smart Pharmaceutical Limited Partnership ( SPLP ) targeted in May 201… read more...

Aptorum Group Limited Announces Repurchase of USD13,500,000 Outstanding Convertible Bonds Due 2019

via: Business Wire at 2019-04-24 00:15:00:000

Aptorum Group Limited (NASDAQ: APM) (Aptorum or the Company), a pharmaceutical company focused on the development and commercialization of therapeutic and diagnostic technologies to tackle unmet medical needs, announced today that the Company, in a privately-n… read more...

Aptorum Group Limited Announces Repurchase of USD13,500,000 Outstanding Convertible Bonds Due 2019

via: Business Wire at 2019-04-24 00:15:00:000

Aptorum Group Limited (NASDAQ: APM) (Aptorum or the Company), a pharmaceutical company focused on the development and commercialization of therapeutic and diagnostic technologies to tackle unmet medical needs, announced today that the Company, in a privately-n… read more...

Aptorum Group Limited Announces Repurchase of USD13,500,000 Outstanding Convertible Bonds Due 2019

via: Business Wire at 2019-04-24 00:15:00:000

Aptorum Group Limited (NASDAQ: APM) (Aptorum or the Company), a pharmaceutical company focused on the development and commercialization of therapeutic and diagnostic technologies to tackle unmet medical needs, announced today that the Company, in a privately-n… read more...

Aptorum Group Limited reports FY results

via: SeekingAlpha at 2019-04-15 04:01:44:000

Aptorum Group Limited (NASDAQ: APM ): FY GAAP EPS of -$0.53. More news on: Aptorum Group Limited, Earnings news and commentary, Read more … read more...

Aptorum Group Limited reports FY results

via: SeekingAlpha at 2019-04-15 04:01:44:000

Aptorum Group Limited (NASDAQ: APM ): FY GAAP EPS of -$0.53. More news on: Aptorum Group Limited, Earnings news and commentary, Read more … read more...

Aptorum Group Limited reports FY results

via: SeekingAlpha at 2019-04-15 04:01:44:000

Aptorum Group Limited (NASDAQ: APM ): FY GAAP EPS of -$0.53. More news on: Aptorum Group Limited, Earnings news and commentary, Read more … read more...

Aptorum Group Limited Reports 2018 Fiscal Year Financial Results and Business Update

via: Business Wire at 2019-04-15 04:00:00:000

Aptorum Group Ltd. (NASDAQ: APM), a preclinical stage pharmaceutical company developing and commercializing a broad portfolio of projects under development of therapeutic and diagnostic technologies to tackle unmet medical needs, today provided a business update and announced financial resul… read more...

Aptorum Group Limited Reports 2018 Fiscal Year Financial Results and Business Update

via: Business Wire at 2019-04-15 04:00:00:000

Aptorum Group Ltd. (NASDAQ: APM), a preclinical stage pharmaceutical company developing and commercializing a broad portfolio of projects under development of therapeutic and diagnostic technologies to tackle unmet medical needs, today provided a business update and announced financial resul… read more...

Aptorum Group Limited Reports 2018 Fiscal Year Financial Results and Business Update

via: Business Wire at 2019-04-15 04:00:00:000

Aptorum Group Ltd. (NASDAQ: APM), a preclinical stage pharmaceutical company developing and commercializing a broad portfolio of projects under development of therapeutic and diagnostic technologies to tackle unmet medical needs, today provided a business update and announced financial resul… read more...

Aptorum Group Limited Announces Appointment of Head of R&D and Chief Operating Officer

via: Business Wire at 2019-04-01 05:30:00:000

Aptorum Group Limited (Nasdaq: APM) (Aptorum) announced today, the appointment of Dr. Thomas Wai-yip Lee as Head of Research and Development (Head of R&D) and Dr. Angel Siu-yan Ng as Chief Operating Officer (COO) of Aptorum, effective on Ap… read more...

Aptorum Group Limited Announces Appointment of Head of R&D and Chief Operating Officer

via: Business Wire at 2019-04-01 05:30:00:000

Aptorum Group Limited (Nasdaq: APM) (Aptorum) announced today, the appointment of Dr. Thomas Wai-yip Lee as Head of Research and Development (Head of R&D) and Dr. Angel Siu-yan Ng as Chief Operating Officer (COO) of Aptorum, effective on Ap… read more...

Aptorum Group Limited Announces Appointment of Head of R&D and Chief Operating Officer

via: Business Wire at 2019-04-01 05:30:00:000

Aptorum Group Limited (Nasdaq: APM) (Aptorum) announced today, the appointment of Dr. Thomas Wai-yip Lee as Head of Research and Development (Head of R&D) and Dr. Angel Siu-yan Ng as Chief Operating Officer (COO) of Aptorum, effective on Ap… read more...

Eyes On Boeing, Nvidia, Disney, Nike And WageWorks (Stocks To Watch Podcast)

via: SeekingAlpha at 2019-03-17 03:48:57:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you… read more...

Eyes On Boeing, Nvidia, Disney, Nike And WageWorks (Stocks To Watch Podcast)

via: SeekingAlpha at 2019-03-17 03:48:57:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you… read more...

Eyes On Boeing, Nvidia, Disney, Nike And WageWorks (Stocks To Watch Podcast)

via: SeekingAlpha at 2019-03-17 03:48:57:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you… read more...

Stocks To Watch: Eyes On Boeing, Nvidia, Disney, Nike And WageWorks

via: SeekingAlpha at 2019-03-16 05:13:58:000

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Interest rates are back in the spotlight with a Federal Reserve interest rate decis… read more...

Aptorum Group (APM) Presents At Barclays Global Healthcare Conference - Slideshow

via: SeekingAlpha at 2019-03-14 10:30:08:000

The following slide deck was published by Aptorum Group Limited in conjunction with this Read more … read more...

Aptorum Group (APM) Presents At Barclays Global Healthcare Conference - Slideshow

via: SeekingAlpha at 2019-03-14 10:30:08:000

The following slide deck was published by Aptorum Group Limited in conjunction with this Read more … read more...

Aptorum Group Limited to Present at the Barclays Global Healthcare Conference 2019

via: Business Wire at 2019-03-08 09:49:00:000

Presentation time updated to 10:15 a.m. ET on March 14 th , 2019 Aptorum Group Limited (NASDAQ:APM), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and diagnostic technologies to t… read more...

Aptorum Group Limited to Present at the Barclays Global Healthcare Conference 2019

via: Business Wire at 2019-03-08 09:49:00:000

Presentation time updated to 10:15 a.m. ET on March 14 th , 2019 Aptorum Group Limited (NASDAQ:APM), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and diagnostic technologies to t… read more...

Aptorum Group Limited to Present at the Barclays Global Healthcare Conference 2019

via: Business Wire at 2019-03-08 09:49:00:000

Presentation time updated to 10:15 a.m. ET on March 14 th , 2019 Aptorum Group Limited (NASDAQ:APM), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and diagnostic technologies to t… read more...

Aptorum Group Limited to Present at the Barclays Global Healthcare Conference 2019

via: Business Wire at 2019-03-08 09:49:00:000

Presentation time updated to 10:15 a.m. ET on March 14 th , 2019 Aptorum Group Limited (NASDAQ:APM), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and diagnostic technologies to t… read more...

Aptorum Group Limited to Present at the Barclays Global Healthcare Conference 2019

via: Business Wire at 2019-03-08 09:49:00:000

Presentation time updated to 10:15 a.m. ET on March 14 th , 2019 Aptorum Group Limited (NASDAQ:APM), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and diagnostic technologies to t… read more...

Aptorum Group Limited to Present at the Barclays Global Healthcare Conference 2019

via: Business Wire at 2019-03-04 06:26:00:000

Aptorum Group Limited (NASDAQ: APM), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and diagnostic technologies to tackle unmet medical needs, today announced that senior management will present a … read more...

Aptorum Group Limited to Present at the Barclays Global Healthcare Conference 2019

via: Business Wire at 2019-03-04 06:26:00:000

Aptorum Group Limited (NASDAQ: APM), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and diagnostic technologies to tackle unmet medical needs, today announced that senior management will present a … read more...

Aptorum Group Limited to Present at the Barclays Global Healthcare Conference 2019

via: Business Wire at 2019-03-04 06:26:00:000

Aptorum Group Limited (NASDAQ: APM), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and diagnostic technologies to tackle unmet medical needs, today announced that senior management will present a … read more...

Week In Review: $1.5 Billion In China Deals With One Week Left In 2018

via: SeekingAlpha at 2018-12-23 08:57:55:000

Deals and Financings Xynomic Pharma, a US-China oncology company, has acquired a worldwide license to an mTORC1/2 inhibitor developed by Boehringer Ingelheim in exchange for an $800 million package of upfront, milestone and royalty payments. BI has completed a successful Phase I trial of B… read more...

Week In Review: $1.5 Billion In China Deals With One Week Left In 2018

via: SeekingAlpha at 2018-12-23 08:57:55:000

Deals and Financings Xynomic Pharma, a US-China oncology company, has acquired a worldwide license to an mTORC1/2 inhibitor developed by Boehringer Ingelheim in exchange for an $800 million package of upfront, milestone and royalty payments. BI has completed a successful Phase I trial of B… read more...

Week In Review: $1.5 Billion In China Deals With One Week Left In 2018

via: SeekingAlpha at 2018-12-23 08:57:55:000

Deals and Financings Xynomic Pharma, a US-China oncology company, has acquired a worldwide license to an mTORC1/2 inhibitor developed by Boehringer Ingelheim in exchange for an $800 million package of upfront, milestone and royalty payments. BI has completed a successful Phase I trial of B… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided for free by IEX